CRISPR-Based Gene Drive Eradicates Malaria Mosquitoes in Trial

common.volume$25,566

common.deadlineMar 12, 2026

Market Probability Chart

Forecast

AI Analysis Active

Live

Insufficient Data for Projection

common.about_results

Target Malaria consortium and Broad Institute researchers have completed controlled island trial with dramatic results. Pre-print servers show 99.7% suppression of Anopheles population. Bioethics forums and science journalists are tracking regulatory approval announcements expected within hours.

common.select_outcome

common.buy_sharescommon.max_limit: 10,000

common.shares

common.avg_cost

50¢common.per_share

common.investing$5.00

common.potential_returncommon.if_resolves YES

$10.00

common.secured_by